Vance Barbara A, Harley Patricia H, Backlund Peter S, Ward Yvona, Phelps Tracy L, Gress Ronald E
National Institutes of Health, National Cancer Institute, Center for Cancer Research, Experimental Transplantation and Immunology Branch, Bethesda, MD 20892-1306, USA.
Arch Biochem Biophys. 2005 Jun 1;438(1):11-20. doi: 10.1016/j.abb.2005.04.009.
CD69 is thought to be a pluripotent signaling molecule expressed on the surface of a number of activated leukocytes including B, T, and NK cells, monocytes, neutrophils, and platelets. While some advances have been made regarding the mechanisms by which CD69 may participate in such diverse functions as cell aggregation, cellular cytotoxicity, and release of cytokines and inflammatory mediators, the most proximal links of signal initiation have not been identified. Our study has identified, by immunoprecipitation and direct protein sequencing (LC/MS/MS), binding of CD69 to an N-terminal protein fragment of calreticulin expressed on the cell surface of human PBMCs. Given the recently identified roles calreticulin plays in cell adhesion and angiogensis, the identification of CD69 binding directly to calreticulin may provide insights into mechanism(s) by which CD69 or other CD69 family members, i.e., LLT1 and AICL participates in such diverse functions.
CD69被认为是一种多能信号分子,表达于多种活化白细胞表面,包括B细胞、T细胞、NK细胞、单核细胞、中性粒细胞和血小板。虽然在CD69参与细胞聚集、细胞毒性以及细胞因子和炎症介质释放等多种功能的机制方面已取得一些进展,但信号起始的最直接联系尚未明确。我们的研究通过免疫沉淀和直接蛋白质测序(液相色谱/串联质谱法),确定了CD69与人外周血单个核细胞(PBMC)表面表达的钙网蛋白N端蛋白片段结合。鉴于最近发现钙网蛋白在细胞黏附和血管生成中发挥的作用,CD69与钙网蛋白直接结合的鉴定可能为CD69或其他CD69家族成员(即LLT1和AICL)参与多种功能的机制提供见解。